UK markets close in 40 minutes

HBM Healthcare Investments AG (0QOC.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
187.02+0.04 (+0.02%)
As of 06:03PM BST. Market open.

HBM Healthcare Investments AG

Bundesplatz 1
Zug CH-6300
Switzerland
41 43 888 7171
https://www.hbmhealthcare.com

Sector(s)
Industry
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Andreas Wicki Ph.D.Chief Executive Officer172.46kN/A1958
Mr. Erwin TroxlerChief Financial Officer104kN/A1970
Dr. Benedikt Suter Ph.D.Secretary to the Board of DirectorsN/AN/A1964
Dr. Alexander G. Asam M.B.A., Ph.D.Investment AdvisorN/AN/A1966
Dr. Thomas Thaler Ph.D.Investment ProfessionalN/AN/AN/A
Amounts are as of 31 December 2016, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

Corporate governance

HBM Healthcare Investments AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.